| Second Ray: Health And Wellness Pc | |
|
428 S 2nd St Sterling CO 80751-4219 | |
| (406) 212-4523 | |
| (402) 337-8898 |
| Full Name | Second Ray: Health And Wellness Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 428 S 2nd St, Sterling, Colorado |
| Authorized Official Name and Position | Keyna Schlup (MANAGING PHYSICIAN) |
| Authorized Official Contact | 4062124523 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Second Ray: Health And Wellness Pc 428 S 2nd St Sterling CO 80751-4219 Ph: (406) 212-4523 | Second Ray: Health And Wellness Pc 428 S 2nd St Sterling CO 80751-4219 Ph: (406) 212-4523 |
| NPI Number | 1184279234 |
|---|---|
| Provider Enumeration Date | 08/06/2019 |
| Last Update Date | 08/06/2019 |
| Medicare PECOS PAC ID | 9032440276 |
|---|---|
| Medicare Enrollment ID | O20191018002240 |
News Archive
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has been accepted for formal review.
Editorials and opinion pieces are responding to the GAVI Alliance pledging conference, which raised $4.3 billion for childhood vaccinations.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.
Your body's acid/alkaline homeostasis, or maintenance of an adequate pH balance in tissues and organs, is important for good health.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184279234 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Keyna I Schlup |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1609172782 PECOS PAC ID: 5395989917 Enrollment ID: I20130923000373 |
News Archive
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has been accepted for formal review.
Editorials and opinion pieces are responding to the GAVI Alliance pledging conference, which raised $4.3 billion for childhood vaccinations.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.
Your body's acid/alkaline homeostasis, or maintenance of an adequate pH balance in tissues and organs, is important for good health.
› Verified 3 days ago
News Archive
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has been accepted for formal review.
Editorials and opinion pieces are responding to the GAVI Alliance pledging conference, which raised $4.3 billion for childhood vaccinations.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.
Your body's acid/alkaline homeostasis, or maintenance of an adequate pH balance in tissues and organs, is important for good health.
› Verified 3 days ago
Sterling Regional Medcenter Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 615 Fairhurst St, Sterling, CO 80751 Phone: 970-522-0122 Fax: 970-522-8532 | |
Ncmc Specialty Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1405 S 8th Ave, Ste 104, Sterling, CO 80751 Phone: 970-526-8181 | |
Blue Sage Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 615 Fairhurst St, Sterling, CO 80751 Phone: 970-522-0122 | |
Pvmg, Primary Care, Sterling Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 620 Iris Dr, Sterling, CO 80751 Phone: 970-522-7266 | |
High Country Internal Medicine, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 620 Iris Dr, Sterling, CO 80751 Phone: 970-522-7266 Fax: 970-522-4258 | |
Securemd Professionals - Colorado Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 S 3rd Ave, Sterling, CO 80751 Phone: 215-589-9001 Fax: 215-589-9030 |